Alpha DNA Investment Management’s Sensata Technologies ST Stock Holding History

Alpha DNA Investment Management’s Portfolio ST Stock Details ST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-25,890	Closed	-$1.42M	–	145
2021 Q3	$1.42M	Buy	25,890 +717	+3%	+$41.2K	0.96%	52
2021 Q2	$1.46M	Buy	25,173 +25,034	+18,010%	+$1.46M	0.99%	50
2021 Q1	$8K	Sell	139 -14,009	-99%	-$808K	0.01%	310
2020 Q4	$746K	Buy	+14,148	New	+$680K	0.79%	54

Other funds holding ST

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Alpha DNA Investment Management's ST Position: Q4 2021 in Review

Alpha DNA Investment Management sold out of Sensata Technologies (ST) in Q4 2021, closing a stake of 25,890 shares — an estimated $1.42M sold.

Alpha DNA Investment Management first reported a position in ST in Q4 2020 and held it in 4 quarters. The position peaked at $1.46M in Q2 2021. 380 funds tracked by Wall St. Rank hold ST as of Q4 2021.

Alpha DNA Investment Management reported no remaining Sensata Technologies position as of Q4 2021 after selling out during the quarter.
Alpha DNA Investment Management sold 25,890 Sensata Technologies shares in Q4 2021, an estimated $1.42M.
Alpha DNA Investment Management first reported a position in Sensata Technologies in Q4 2020 and held it in 4 quarters.
Alpha DNA Investment Management's Sensata Technologies position peaked at $1.46M in Q2 2021.
380 funds tracked by Wall St. Rank held Sensata Technologies as of Q4 2021.

Based on Alpha DNA Investment Management's 13F filing for Q4 2021, filed 11 Feb 2022.